Both in Pharmaceuticals
Jupiter Neurosciences vs Cadrenal Therapeutics
Over the past year JUNS returned −97.9% and CVKD returned −92.7%; their daily moves had a correlation of -0.04.
JUNS −97.9% CVKD −92.7%Growth of $1, one year, split-adjusted
| Metric | JUNS | CVKD |
|---|---|---|
| Price | $2.05 | $0.9850 |
| Market cap | $2.7M | $3.5M |
| Today | −13.50% | +4.41% |
| 1 month | −18.0% | +1.5% |
| 6 months | −93.0% | −84.5% |
| Year to date | −97.3% | −85.5% |
| 1 year | −98.1% | −92.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 86.9% | — |
| Net margin | −9380.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 41.8× | — |
| Net cash | -$6.6K | $2.4M |
| Dividend yield | — | — |
| Volatility (60d) | 903.4% | 87.2% |
| Short % of float | 6.0% | 9.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).